Literature DB >> 2903376

Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

G J Kurtzman1, B Cohen, P Meyers, A Amunullah, N S Young.   

Abstract

In two children with acute lymphocytic leukaemia in whom severe anaemia developed, serum samples collected over 9-12 months showed high concentrations of B19 parvovirus, the aertiological agent of fifth disease. In one patient, anaemia recurred with the reappearance of virus in serum; in the other, the anaemia persisted. Smears of bone marrow aspirates obtained during periods of viraemia showed giant pronormoblasts and either absent mature erythroid cells or erythroid hypoplasia. Parvovirus replication in the marrow was detected by Southern blot of cellular DNA. An underlying immune deficit was suggested by low titres of specific antibodies against B19 parvovirus. Treatment of one patient with plasma containing specific antibodies against parvovirus resulted in a transient fall in serum virus levels, the appearance of reticulocytes, and symptoms of fifth disease.

Entities:  

Mesh:

Year:  1988        PMID: 2903376     DOI: 10.1016/s0140-6736(88)90233-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

Review 1.  The immunocompromised patient and transfusion.

Authors:  K G Badami
Journal:  Postgrad Med J       Date:  2001-04       Impact factor: 2.401

Review 2.  Pathogenesis of human parvovirus B19 in rheumatic disease.

Authors:  J R Kerr
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

3.  Genetic diversity within human erythroviruses: identification of three genotypes.

Authors:  Annabelle Servant; Syria Laperche; Francis Lallemand; Valérie Marinho; Guillemette De Saint Maur; Jean François Meritet; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 4.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

5.  Concurrence of transient asplenia and pure red cell aplasia.

Authors:  M F Ozkaynak; J A Ortega; J Miller
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

6.  Study on clinical characteristics and follow-up visit of acquired aplastic anemia associated with parvovirus B19 infection.

Authors:  Jin-quan Wen; Nan Zhou; Dan Li; Hai-ling Feng; Hua Wang
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

7.  Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2.

Authors:  H J O'Neill; P V Coyle
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Authors:  Ning Zhi; Ian P Mills; Jun Lu; Susan Wong; Claudia Filippone; Kevin E Brown
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Authors:  G J Kurtzman; B J Cohen; A M Field; R Oseas; R M Blaese; N S Young
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens.

Authors:  J P Clewley
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.